These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28523460)

  • 1. Evaluation of the effect of torsemide on warfarin dosage requirements.
    Lai S; Momper JD; Yam FK
    Int J Clin Pharm; 2017 Aug; 39(4):831-835. PubMed ID: 28523460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probable interaction between warfarin and torsemide.
    Bird J; Carmona C
    Ann Pharmacother; 2008 Dec; 42(12):1893-8. PubMed ID: 19017829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new regimen for starting warfarin therapy in out-patients.
    Oates A; Jackson PR; Austin CA; Channer KS
    Br J Clin Pharmacol; 1998 Aug; 46(2):157-61. PubMed ID: 9723825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the impact of body mass index on warfarin requirements in hospitalized patients.
    Tellor KB; Nguyen SN; Bultas AC; Armbruster AL; Greenwald NA; Yancey AM
    Ther Adv Cardiovasc Dis; 2018 Aug; 12(8):207-216. PubMed ID: 29914293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of warfarin dosing requirements after bariatric surgery in patients requiring long-term warfarin therapy.
    Irwin AN; McCool KH; Delate T; Witt DM
    Pharmacotherapy; 2013 Nov; 33(11):1175-83. PubMed ID: 23744816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of body mass index on 90-day warfarin requirements: a retrospective chart review.
    Soyombo BM; Taylor A; Gillard C; Wilson C; Bailey Wheeler J
    Ther Adv Cardiovasc Dis; 2021; 15():17539447211012803. PubMed ID: 34120532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral corticosteroids on chronic warfarin therapy.
    Hazlewood KA; Fugate SE; Harrison DL
    Ann Pharmacother; 2006 Dec; 40(12):2101-6. PubMed ID: 17119104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A probable interaction between warfarin and the antiretroviral TRIO study regimen.
    Liedtke MD; Vanguri A; Rathbun RC
    Ann Pharmacother; 2012 Nov; 46(11):e34. PubMed ID: 23115227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Warfarin-bosentan interaction. Risk of big INR changes].
    Holm L; Jansson A; Noher H
    Lakartidningen; 2007 Aug 8-21; 104(32-33):2248. PubMed ID: 17822204
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized controlled trial of empiric warfarin dose reduction with the initiation of doxycycline therapy.
    Dowd MB; Kippes KA; Witt DM; Delate T; Martinez K
    Thromb Res; 2012 Aug; 130(2):152-6. PubMed ID: 22221937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home medicines reviews in Australian war veterans taking warfarin do not influence international normalised ratio control.
    Bereznicki LR; van Tienen EC; Stafford A
    Intern Med J; 2016 Mar; 46(3):288-94. PubMed ID: 26602177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study.
    Gemmati D; Burini F; Talarico A; Fabbri M; Bertocco C; Vigliano M; Moratelli S; Cuneo A; Serino ML; Avato FM; Tisato V; Gaudio RM
    PLoS One; 2016; 11(9):e0162084. PubMed ID: 27606428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.
    Ghaswalla PK; Harpe SE; Tassone D; Slattum PW
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):352-60. PubMed ID: 23089199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential interaction between warfarin and atovaquone.
    Hidalgo K; Lyles A; Dean SR
    Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bosentan and warfarin interaction.
    Murphey LM; Hood EH
    Ann Pharmacother; 2003; 37(7-8):1028-31. PubMed ID: 12841813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarin.
    Vijenthira A; Le Gal G; Castellucci LA; Carrier M
    Thromb Res; 2014 Sep; 134(3):584-6. PubMed ID: 25037497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preemptive dose reduction of warfarin in patients initiating metronidazole.
    Holt RK; Anderson EA; Cantrell MA; Shaw RF; Egge JA
    Drug Metabol Drug Interact; 2010; 25(1-4):35-9. PubMed ID: 21417792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin monitoring in ambulatory older individuals receiving antimicrobial therapy.
    Raebel MA; Witt DM; Carroll NM; Magid DJ
    Pharmacotherapy; 2005 Aug; 25(8):1055-61. PubMed ID: 16207095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated international normalized ratio associated with use of dronedarone and warfarin.
    Pogge EK; Haber SL
    Ann Pharmacother; 2011 Sep; 45(9):e46. PubMed ID: 21811004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Warfarin Dosages and International Normalized Ratios Before and After Roux-en-Y Gastric Bypass Surgery.
    Steffen KJ; Wonderlich JA; Erickson AL; Strawsell H; Mitchell JE; Crosby RD
    Pharmacotherapy; 2015 Sep; 35(9):876-80. PubMed ID: 26406775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.